English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/101277
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 19 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar otros formatos: Exportar EndNote (RIS)Exportar EndNote (RIS)Exportar EndNote (RIS)
Título

Glucocerebrosidase inhibitors for the treatment of Gaucher disease

Autor Trapero, Ana; Llebaria, Amadeu
Fecha de publicación 2013
EditorFuture Science
Citación Future Medicinal Chemistry 5: 573- 590 (2013)
ResumenGaucher disease is a progressive lysosomal storage disorder caused by a deficiency in the activity of γ-glucocerebrosidase and is characterized by the accumulation of the glycosphingolipid glucosylceramide in the lysosomes of macrophages that leads to dysfunction in multiple organ system. An emerging strategy for the treatment of Gaucher disease is pharmacological chaperone therapy, based on the use of γ-glucocerebrosidase inhibitors that are capable of enhancing residual hydrolytic activity at subinhibitory concentrations. In this article, the most common lysosomal storage disorder, Gaucher disease, is introduced and the current therapeutic strategies based on the use of enzyme inhibitors to ameliorate this disease are discussed, with a focus on the efforts being made toward finding and optimizing novel molecules as pharmacological chaperones for Gaucher disease that offer the promise to remedy this malady.
URI http://hdl.handle.net/10261/101277
DOI10.4155/fmc.13.14
Identificadoresdoi: 10.4155/fmc.13.14
issn: 1756-8919
e-issn: 1756-8927
Aparece en las colecciones: (IQM) Artículos
(IQAC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.